Patients on emicizumab prophylaxis with previously tolerized inhibitors: Is there a risk of inhibitors recurrence?

Early View

LETTER TO THE EDITOR

Eman Hassan,

Corresponding Author

Department of Paediatric Haematology, Birmingham Children's Hospital, Birmingham, UK

Haematology and Oncology Unit, Faculty of Medicine, Alexandria University, Department of Paediatrics, Alexandria, Egypt

Correspondence

Eman Hassan, Department of Paediatric Haematology, Birmingham Children's Hospital, Birmingham, UK.

Email: eman.hassan@nhs.net

Search for more papers by this authorJonathan Lancashire,

Department of Paediatric Haematology, Birmingham Children's Hospital, Birmingham, UK

Search for more papers by this authorJayashree Motwani,

Department of Paediatric Haematology, Birmingham Children's Hospital, Birmingham, UK

Search for more papers by this author PDFPDF Please review our Terms and Conditions of Use and check box below to share full-text version of article.

I have read and accept the Wiley Online Library Terms and Conditions of Use

Shareable Link

Use the link below to share a full-text version of this article with your friends and colleagues. Learn more.

Share a link

Share on

No abstract is available for this article.

留言 (0)

沒有登入
gif